Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Classic Cardiovascular Risk Factors and Certain Comorbidities May Contribute to the Risk of Thrombembolic and Bleeding Events in Patients with Classical Myeloproliferative Neoplasms

Susanne Isfort, MD, Andrea Kaifie, MD, Karla Schmitt, MD, Edgar Jost, MD, Tim H. Bruemmendorf, MD, Steffen Koschmieder, MD

Blood (2015) 126 (23): 5195.

https://doi.org/10.1182/blood.V126.23.5195.5195

Published: 2015

Journal Articles

Cooperating Effect of Rps14 , Csnk1a1 and miRNA145/miRNA146a Haploinsufficiency in the Activation of the Innate Immune System in Del(5q) MDS

Schneider K. Rebekka, MD, Monica Schenone, PhD, Monica Ferreira Ventura, PhD, Fabian Beier, MD, Tim H. Bruemmendorf, MD, Ulrich Germing, MD, Uwe Platzbecker, MD, Guntram Büsche, MD, Marie E. McConkey, PhD, Christopher S Waters, R. Coleman Lindsley, MDPhD, Benjamin L. Ebert, MD

Blood (2015) 126 (23): 356.

https://doi.org/10.1182/blood.V126.23.356.356

Published: 2015

Journal Articles

Comprehensive Analysis of Telomere Biology in Patients with Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome: Further Evidence for a Common Mechanism

Anne-Sophie Bouillon, Monica S. Ferreira, PhD, Benjamin Werner, PhD, Sebastian Hummel, Jens P. Panse, MD, Petra Reinecke, MD, Jennifer Schemenau, Rainer Haas, MD, Arne Traulsen, PhD, Tim H. Bruemmendorf, MD, Ulrich Germing, MD, Fabian Beier, MD

Blood (2015) 126 (23): 2858.

https://doi.org/10.1182/blood.V126.23.2858.2858

Published: 2015

Journal Articles

Comorbidity Scales in Patients with Myeloproliferative Neoplasms: Which One Fits Best?

Susanne Isfort, MD, Andrea Kaifie, MD, Karla Bennemann, MD, Edgar Jost, MD, Jens Panse, MD, Tim H Bruemmendorf, MD, Steffen Koschmieder, MD

Blood (2014) 124 (21): 1828.

https://doi.org/10.1182/blood.V124.21.1828.1828

Published: 2014

Journal Articles

Diagnosis and Treatment of Myeloproliferative Neoplasms in Germany: First Results from the SAL-MPN Registry

Andrea Kaifie, MD, Susanne Isfort, MD, Dominik Wolf, MD, Mathias Hanel, MD, Christoph Maintz, MD, Norbert Gattermann, MD PhD, Uwe Platzbecker, MD, Eray Goekkurt, MD, Ina Boeters, MD, Richard Hansen, MD, Fabian Lang, MD, Joachim R. Goethert, Karla Bennemann, MD, Christoph Rollig, MD MSC, Hubert Serve, MD, Wolfgang E Berdel, MD, Gerhard Ehninger, MD, Tim H Bruemmendorf, MD, Steffen Koschmieder, MD

Blood (2014) 124 (21): 5561.

https://doi.org/10.1182/blood.V124.21.5561.5561

Published: 2014

Journal Articles

Dissecting Genomic Aberrations In CML and Bcr-Abl Negative Myeloproliferative Neoplasms By The Use Of Multiplex-PCR and Parallel Resequencing

Martin M. Kirschner, Mirle Schemionek, Claudia Schubert, Nicolas Chatain, Stephanie Sontag, Susanne Isfort, Nadina Ortiz-Brüchle, Karla Bennemann, Klaus Zerres, Martin Zenke, Tim H. Bruemmendorf, MD, Steffen Koschmieder

Blood (2013) 122 (21): 1612.

https://doi.org/10.1182/blood.V122.21.1612.1612

Published: 2013

Journal Articles

Sustained Alterations In Bone Marrow Stromal Cells From Patients With Myeloproliferative Neoplasms (MPN) Contribute To Remodelling Of The Bone Marrow Microenvironment Prior To The Manifestation Of Myelofibrosis

Rebekka K. Schneider, MD, Isabelle Leisten, Susanne Ziegler, PhD, Anne Schumacher, Björn Rath, MD, Dirk Fahrenkamp, Gerhard Mueller-Newen, PhD, Martina Crysandt, MD, Stefan Wilop, MD, Edgar Jost, MD, Ruth Knuechel, MD, Tim H. Bruemmendorf, MD, Patrick Ziegler, PhD

Blood (2013) 122 (21): 4102.

https://doi.org/10.1182/blood.V122.21.4102.4102

Published: 2013

Journal Articles

Iron Stores in Patients with Myelodysplasia and Aplastic Anemia.

Peter Nielsen, Tim H. Bruemmendorf, Regine Grosse, Rainer Engelhardt, Nicolaus Kroeger, Hartmut Kabisch, Oliver Leismann, Roland Fischer, Axel R. Zander

Blood (2006) 108 (11): 3726.

https://doi.org/10.1182/blood.V108.11.3726.3726

Published: 2006

NARROW

Classic Cardiovascular Risk Factors and Certain Comorbidities May Contribute to the Risk of Thrombembolic and Bleeding Events in Patients with Classical Myeloproliferative Neoplasms

Cooperating Effect of Rps14 , Csnk1a1 and miRNA145/miRNA146a Haploinsufficiency in the Activation of the Innate Immune System in Del(5q) MDS

Comprehensive Analysis of Telomere Biology in Patients with Aplastic Anemia and Hypoplastic Myelodysplastic Syndrome: Further Evidence for a Common Mechanism

Comorbidity Scales in Patients with Myeloproliferative Neoplasms: Which One Fits Best?

Diagnosis and Treatment of Myeloproliferative Neoplasms in Germany: First Results from the SAL-MPN Registry

Dissecting Genomic Aberrations In CML and Bcr-Abl Negative Myeloproliferative Neoplasms By The Use Of Multiplex-PCR and Parallel Resequencing

Sustained Alterations In Bone Marrow Stromal Cells From Patients With Myeloproliferative Neoplasms (MPN) Contribute To Remodelling Of The Bone Marrow Microenvironment Prior To The Manifestation Of Myelofibrosis

Iron Stores in Patients with Myelodysplasia and Aplastic Anemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only